Research

Overview

Dr. Mushtaq is a clinical investigator with a focus on hematologic malignancies, hematopoietic stem cell transplantation, cellular therapy, immunotherapy, and global health. He has a long history of research productivity with over 1000 citations.

• Impact of Microbiota on outcomes after chimeric antigen receptor (CAR) T-cell therapy, HMCT Division, Internal Funding, Site-PI
• Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion before Tumor-Infiltrating Lymphocytes Therapy with Lifileucel in Metastatic Melanoma, Iovance Biotherapeutics, Inc., PI
• A Phase lb, Open-Label, Randomized, Dose-Finding, Multicenter Study To Evaluate The Safety, Efficacy, And Pharmacokinetics Of GDC-8264 In Combination With Standard Of Care In The Treatment Of Acute Graft-Versus-Host Disease In Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (GA43861), Genentech, Inc., Site-PI

• Mushtaq, Muhammad., Umair, Shahzad, Moazzam, Chaudhary, Sibgha., Gull, Luder, Mary, Ahmed, Nausheen, Abdelhakim, Haitham, Bansal, Rajat, Balusu, Ramesh, DeJarnette, Shaun, Divine, Clint, Kribs, Robert, Shune, Leyla, Singh, Anurag., K., Ganguly, Siddhartha, Abhyankar, Sunil., H., McGuirk, Joseph., P.. 2021. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.. Transplantation and Cellular Therapy, 27 (9), 796.e1-796.e7
• Shahzad, M, Hussain, A, Tariq, E, Anwar, I, Faisal, M., S, Syed, L, Karam, A, Chaudhary, S., G, Ahmed, N, Bansal, R, Khurana, S, Singh, A., K, Byrd, K., P, Hematti, P, Abhyankar, S., H, McGuirk, J., P, Mushtaq, M., U. 2023. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis.. Clinical lymphoma, myeloma & leukemia, 23 (3), 178-187
• Siddiqui, Raheel., Sufian, Chaudhary, Sibgha., Gull, Shahzad, Moazzam, Anwar, Iqra, Hussain, Ali, Ahmed, Nausheen, Abhyankar, Sunil., Hari, Shune, Leyla, Hematti, Peiman, Male, Heather, Khosa, Faisal, Lin, Tara, McGuirk, Joseph., P., Callander, Natalie., Scott, Mushtaq, Muhammad., Umair. 2022. Gender Disparities in the National Institutes of Health Funding for Hematologic Malignancies and Cellular Therapies. Leukemia & lymphoma, 1-6
• Shahzad, Moazzam, Chaudhary, Sibgha., Gull, Zafar, Muhammad., Umair, Hassan, Maha., A., Hussain, Ali, Ali, Fatima, Anwar, Iqra, Ahmed, Mamoon, Ahmed, Nausheen, Khurana, Sharad, Rauf, Muhammad., A., Anwar, Faiz, Hematti, Peiman, Callander, Natalie., S., Abhyankar, Sunil., H., McGuirk, Joseph., P., Mushtaq, Muhammad., Umair. 2022. Impact of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis. Transplant infectious disease : an official journal of the Transplantation Society, e13792
• Shahzad, Moazzam, Chaudhary, Sibgha., Gull, Tariq, Ezza, Mushtaq, Ali, Anwar, Iqra, Ahmed, Nausheen, Bansal, Rajat, Lutfi, Forat, Ramesh, Balusu, Abdelhakim, Haitham, Yacoub, Abdulraheem, Hematti, Peiman, Singh, Anurag, McGuirk, Joseph, Mushtaq, Muhammad., Umair. 2022. Use of Endpoints in Phase III Randomized Controlled Trials for Acute Myeloid Leukemia over the Last 15 Years: A Systematic Review Journal. Leukemia and Lymphoma
• Khanam, R., Shahzad, M., Chaudhary, S.., G., Ali, F., Shah, Z., Pachika, P.., S., Ahmed, Z., Chattaraj, A., Masood, A., Ahmed, N., Bansal, R., Balusu, R., Shune, L., Anwar, F., Hematti, P., McGuirk, J.., P., Yacoub, A., Mushtaq, M.., U.. 2022. Outcomes After Venetoclax With Hypomethylating Agents in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis. Leukemia & lymphoma, 1-8
• Mushtaq, M., U, Shahzad, M, Tariq, E, Iqbal, Q, Chaudhary, S., G, Zafar, M., U, Anwar, I, Ahmed, N, Bansal, R, Singh, A., K, Abhyankar, S., H, Callander, N., S, Hematti, P, McGuirk, J., P. 2022. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis.. Frontiers in oncology, 12, 1005042
• Shahzad, Moazzam, Anwar, Iqra, Siddiqui, Raheel., Suflan, Ahmed, Tehniat., Faraz, Majeed, Mahrukh, Hassan, Maha., Awaiz, Ahmed, Zahoor, Neupan, Karun, Ali, Tayyaba, Faisal, Muhammad., Salman, Naseem, Masooma, Chaudhary, Sibgha., Gull, Balusu, Ramesh, Ahmed, Nausheed, Singh, Anurag., K., Abhyankar, Sunil., H., McGuirk, Joseph., P., Anwer, Faiz, Mushtaq, Muhammad., Umair. 2021. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.. Transplantation and cellular therapy, 27 (10), 877.e1-877.e8
• Mushtaq, M.., U., Harrington, A.., M., Chaudhary, S.., G., Michaelis, L.., C., Carlson, K.., B., Abedin, S., Runass, L., Callander, N.., S., Fallon, M.., J., Juckett, M., Hall, A.., C., Hematti, P., Mattison, R.., J., Atallah, E.., L., Guru Murthy, G.., S.. 2020. Comparison of Salvage Chemotherapy Regimens and Prognostic Significance of Minimal Residual Disease in Relapsed/Refractory Acute Myeloid Leukemia. Leukemia & Lymphoma, 1-9
• Mushtaq, Muhammad., Umair, Papadas, Anthanasios, Pagenkopf, Adam, Flietner, Evan, Morrow, Zachary, Chaudhary, Sibgha., Gull, Asimakopoulos, Fotis. 2018. Tumor Matrix Remodeling and Novel Immunotherapies: The Promise of Matrix-Derived Immune Biomarkers. Journal for immunotherapy of cancer, 6 (1), 65